Health and Healthcare
565 Articles
The short interest data have been released for the August 31 settlement date, and for the selected pharmaceutical stocks, short…
ThinkstockAbbVie Inc. (NYSE: ABBV) has continued to push forward over the past year and shares are actually up 7.3% in…
The August 14 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short…
ThinkstockWith a very nervous market, and the end of summer doldrums upon us, it may be time to look for…
The short interest data have been released for the July 31 settlement date, and for most of the selected pharmaceutical…
Independent research firm Argus has maintained its Buy rating and its $85.00 price target on AbbVie.
ThinkstockThe short interest data have been released for the July 15 settlement date. Pharmaceutical companies are usually involved in a…
AbbVie reported better-than-expected second-quarter financial results Friday before the markets opened.
Abbvie is scheduled to report its second-quarter financial results before the markets open Friday.
Earnings season is hitting its stride next week, and the health care sector, the biotech stocks in particular, have been…
A new report from Jefferies updates the firm's top global pharmaceutical stocks to buy, and these picks make sense for…
The June 30 short interest data have been compared with the previous figures, and across the selected pharmaceutical stocks, short…
A new report from UBS highlights three stocks that the firm likes best now. Not only do they all pay…
How much are big pharmaceutical companies really spending to get their drugs out there in the public eye?
The June 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short…
Our top personal finance-related articles today. Your wallet will thank you later.